The most modern goal of Aesthetic and Functional Medicine.
Lipogems® is a methodology patented by Professor Carlo Tremolada (further information on the patent), exported and developed by many professionals all over the world in order to treat pathologies, relieve pain and regain wellbeing.
Lipogems® is micro-fragmented adipose tissue, the most advanced procedure for true regeneration in various fields. It represents the evolution of both classic lipofilling and mesenchymal stem cell extraction techniques. It is the only device able to reduce, without destroying its structure, the dimensions of the adipose tissue containing microcapillaries and precursors of mesenchymal stem cells. It is applied with a simple injection to those areas where it is necessary to restore the innate healing capacities that have depleted with age, chronic inflammation or severe trauma.
Autologous fat (adipose tissue) becomes a healing tool thanks to a specific procedure that is applied in different areas, from orthopedics to gynecology, as well as aesthetic treatments (for example by way of injection, in order to increase vascular density and consequently tissue regeneration).
Prof. Carlo Tremolada
Scientific director and founder of Image Regenerative Clinic. He is a leading international figure in the medical field, in particular plastic surgery. Thanks to his expertise in research on the regenerative functioning of cells and tissues, today, his invention – the Lipogems® method – is widespread and performed in over 30 countries around the world.
Orthopedics, arthrosis and tendinopathies
Sport and injury recovery
Beauty, plastic and aesthetics
Gynecology and vaginal rejuvenation
Periodontocs and periodontal improvement
From orthopedics to aesthetic medicine, the efficacy and functionality of Lipogems® have been the subject of numerous scientific publications. New applications in various branches of medicine are constantly being studied.
Go to publications
No oxidation or traumatic action on the cell population.
The cell population retains its biochemical potential.
Maximum security of sterility.
Maximum safety in the operating environment.
Injectable product with very fine needles.
Minimal trauma during grafting.
Immediate availability of all material.
Reduction of management and economic operating costs.